Skip to content
Contact About us Swedish residents

Plasma Cell Malignancies

The division is Sweden's largest for plasma cell malignancies. We have broad expertise in all plasma cell diseases.

We have just over 4,300 outpatient visits per year. We carry out all kinds of myeloma treatment, including new therapies such as bispecific T-cell stimulants, intensive chemotherapy, and high-dose therapy with autologous stem cell transplantation. This allows us to offer our patients the possibility to participate in several clinical studies, especially at our center for clinical cancer studies.


The Hematology Center at Karolinska is the largest of its kind in Sweden, and the collaboration between the center and the Karolinska Institutet ensures strong clinical and translational research. Hematology
Bringing together cutting-edge research and world-leading expertise